‘Just a few mouse clicks’: TriNetX offers RWD analytics

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/ipopba)
(Image: Getty/ipopba)

Related tags: research network, Research, Clinical trial, Clinical research, cloud based software, analytical, analytics, Data

Global health research network, TriNetX, has added an analytic self-service offering for simplified analysis of real-world data.

TriNetX’s Treatment Pathways analytic simplifies the analysis of real-world data (RWD) of patient treatment pathways geographically and chronologically.

Alex Eastmen, VP, Product Management at TriNetX, said in a statement, “Studying treatment pathways has always involved resource intensive physician interviews, laborious literature review, difficult analysis of longitudinal data, and writing custom code to visualize data.”

He further explained that with the analytic platform offered by the research network, researchers can get the analysis they need “in minutes with just a few mouse clicks” ​and the data of over 16 countries, representing 300 million patients, is continuously refreshed.

TriNetX Research​, an additional self-service offering works directly with the Treatment Pathways analytic offering. The research platform uses the networks longitudinal clinical and genomic data to develop analytics, from which real-world data can be searched through the Treatment Pathways offering. The organization’s network includes real-time access to de-identified RWD to bolster its analytic capabilities.

Becca Fink, director of Product Management at TriNetX Research, added that the platform gives users the ability to custom analyses for specific indications.

Bolstering the analytical capabilities, TriNetX’s cloud-based platform​, TNX, has on-demand access to longitudinal clinical, genomic, and claims data. From this source, researchers can explore and compare cohort characteristics prior to an event and compare outcomes after.

The TriNetX platform has partnerships with pharmaceutical and health care companies like Sanofi​, Pfizer​, Tufts​, and Allergen​. 

Related news

Show more

Related products

show more

QPS: Global Custom-Built Research Services

QPS: Global Custom-Built Research Services

QPS | 16-Dec-2019 | Product Brochure

Performing complex studies in special populations with remarkable agility. Clinical research just got better with QPS’ Custom-Built Research Services....

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Related suppliers

Follow us

Products

View more

Webinars